Activation of the cell-surface antigen CD95 induces apoptosis of CD95-
bearing tumor cells. In this study, we investigated the antitumor effe
ct of locally produced CD95 ligand (CD95L) on CD95-negative tumor cell
s in vivo. Introduction of CD95L cDNA into murine tumor cells did not
affect growth in vitro but caused rejection in vivo. Neutrophils were
primarily responsible for this rejection. A CD8(+) T cell-mediated pro
tective immunity against subsequent challenge with parental tumor cell
s was also elicited. These results provide evidence for the potential
utility of CD95L in tumor eradication and also reveal a proinflammator
y function of CD95L.